
1. retracted article

science. 1999 jan 15;283(5400):357-62.

fusion-competent vaccines: broad neutralization primary isolates hiv.

lacasse ra(1), follis ke, trahey m, scarborough jd, littman dr, nunberg jh.

author information: 
(1)the montana biotechnology center division biological sciences,
university montana, missoula, mt 59812, usa.

retraction in
    nunberg jh. science. 2002 may 10;296(5570):1025.

comment on
    science. 1999 jan 15;283(5400):336-7.

current recombinant human immunodeficiency virus (hiv) gp120 protein vaccine
candidates unable elicit antibodies capable neutralizing infectivity of
primary isolates patients. here, "fusion-competent" hiv vaccine immunogens
were generated capture transient envelope-cd4-coreceptor structures that
arise hiv binding fusion. transgenic mouse immunization model,
these formaldehyde-fixed whole-cell vaccines elicited antibodies capable of
neutralizing infectivity 23 24 primary hiv isolates diverse geographic
locations genetic clades e. development fusion-dependent
immunogens may lead broadly effective hiv vaccine.

doi: 10.1126/science.283.5400.357 
pmid: 9888845  [indexed medline]

